Your browser doesn't support javascript.
loading
Bortezomib retreatment is effective in relapsed multiple myeloma patients - real-life clinical practice data.
Stork, M; Sevcikova, S; Brozova, L; Spicka, I; Maisnar, V; Minarik, J; Jungova, A; Gregora, E; Velichova, R; Hajek, R; Jelinek, T; Pour, L.
Afiliación
  • Stork M; Department of Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Sevcikova S; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Brozova L; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Spicka I; 1st Medical Department, Clinical Department of Hematology of the First Faculty of Medicine and General Teaching Hospital Charles University, Prague, Czech Republic.
  • Maisnar V; 4th Department of Internal Medicine - Hematology, Faculty Hospital and Charles University in Hradec Kralove, Hradec Kralove, Czech Republic.
  • Minarik J; Department of Hemato-Oncology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
  • Jungova A; Hematology and Oncology Department , Charles University Hospital Pilsen, Pilsen, Czech Republic.
  • Gregora E; Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Velichova R; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Hajek R; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic.
  • Jelinek T; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic.
  • Pour L; Department of Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
Neoplasma ; 67(1): 178-184, 2020 Jan.
Article en En | MEDLINE | ID: mdl-31829027
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bortezomib / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Neoplasma Año: 2020 Tipo del documento: Article País de afiliación: República Checa Pais de publicación: Eslovaquia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Bortezomib / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Neoplasma Año: 2020 Tipo del documento: Article País de afiliación: República Checa Pais de publicación: Eslovaquia